Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP807136.RAgIrwjF6O8HgyYDWQadqqGw0jfyCfyNtyE4iBjeOB2Ho130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP807136.RAgIrwjF6O8HgyYDWQadqqGw0jfyCfyNtyE4iBjeOB2Ho130_assertion type Assertion NP807136.RAgIrwjF6O8HgyYDWQadqqGw0jfyCfyNtyE4iBjeOB2Ho130_head.
- NP807136.RAgIrwjF6O8HgyYDWQadqqGw0jfyCfyNtyE4iBjeOB2Ho130_assertion description "[In conclusion, NK4 gene therapy is a promising strategy to treat HCC based on the pleiotropic functions of NK4 interfering with tumor growth, invasion, metastasis and angiogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807136.RAgIrwjF6O8HgyYDWQadqqGw0jfyCfyNtyE4iBjeOB2Ho130_provenance.
- NP807136.RAgIrwjF6O8HgyYDWQadqqGw0jfyCfyNtyE4iBjeOB2Ho130_assertion evidence source_evidence_literature NP807136.RAgIrwjF6O8HgyYDWQadqqGw0jfyCfyNtyE4iBjeOB2Ho130_provenance.
- NP807136.RAgIrwjF6O8HgyYDWQadqqGw0jfyCfyNtyE4iBjeOB2Ho130_assertion SIO_000772 15905856 NP807136.RAgIrwjF6O8HgyYDWQadqqGw0jfyCfyNtyE4iBjeOB2Ho130_provenance.
- NP807136.RAgIrwjF6O8HgyYDWQadqqGw0jfyCfyNtyE4iBjeOB2Ho130_assertion wasDerivedFrom befree-20140225 NP807136.RAgIrwjF6O8HgyYDWQadqqGw0jfyCfyNtyE4iBjeOB2Ho130_provenance.
- NP807136.RAgIrwjF6O8HgyYDWQadqqGw0jfyCfyNtyE4iBjeOB2Ho130_assertion wasGeneratedBy ECO_0000203 NP807136.RAgIrwjF6O8HgyYDWQadqqGw0jfyCfyNtyE4iBjeOB2Ho130_provenance.